Published in Hepatitis Weekly, March 25th, 1996
Vascular methods are available to measure antibodies related to hepatitis C virus (HCV), and their clinical usefulness has been studied. Second-generation antibody to HCV (anti-HCV) is now widely used for the diagnosis of HCV infection.
"Over 90 percent of patients with chronic non-A, non-B liver disease are positive for anti-HCV, but this does not directly reflect HCV viremia," researcher Eriko Yoshimura and colleagues wrote ("Evaluation of Quantitative Assay for Antibody to HCV Core in Patients Treated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.